B · Normal
[Hanyu Pharmaceutical: Plans to invest no more than 380 million yuan in building a peptide drug production line expansion project] On October 26, Hanyu Pharmaceutical (300199.SZ) announced that the company's wholly-owned subsidiary Wuhan Hanyu plans to invest in the construction of a "green and intelligent expansion project for the peptide drug production line in workshops B04 and B06" with an investment scale of no more than 380 million yuan. After the project is completed, it will add an annual production capacity of 10 tons of peptide drugs.
A-share announcement express 🕐 2026-10-26 19:20

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet